Generally the raw materials required for the production of our product are available from several suppliers, yet in some cases the raw materials are only available through one supplier. We have adopted policies to attempt, to the extent feasible, to minimize our raw material supply risks including maintenance of greater levels of raw materials inventory and implementation of multiple raw materials sourcing strategies, especially for critical raw materials. Although to date we have not experienced any significant delays in obtaining any raw materials from our suppliers, we cannot provide assurance that we will not face shortages from one or more of them in the future. We contract with third parties to manufacture the raw materials and the active pharmaceutical ingredient (API) of IMBRUVICA for clinical and commercial uses. We currently do not have internal manufacturing facilities for clinical or commercial production of IMBRUVICA. In addition, we expect in the foreseeable future to continue to rely on third parties for the manufacture of the raw materials and API for IMBRUVICA.
Company profile
Ticker
PCYC
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
943148201
Latest filings (excl ownership)
CT ORDER
Confidential treatment order
15 Jun 15
15-12G
Securities registration termination
5 Jun 15
25-NSE
Exchange delisting
26 May 15
8-K
Completion of Acquisition or Disposition of Assets
26 May 15
POSASR
Automatic shelf registration (post-effective amendment)
26 May 15
S-8 POS
Registration of securities for employees (post-effective amendment)
26 May 15
S-8 POS
Registration of securities for employees (post-effective amendment)
26 May 15
S-8 POS
Registration of securities for employees (post-effective amendment)
26 May 15
S-8 POS
Registration of securities for employees (post-effective amendment)
26 May 15
S-8 POS
Registration of securities for employees (post-effective amendment)
26 May 15
Latest ownership filings
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|